VeriMom¿Es hexapeptide-12 seguro durante el embarazo?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment for 'hexapeptide-12' was identified, and no PubMed reproductive or developmental toxicity studies for this ingredient were found in the available literature. Per CIR/SCCS default approach, absence of reproductive hazard data and absence of harmonised flags supports a default score of 0 for hazard and mechanism; expected dermal absorption for a short peptide is very low so exposure from topical cosmetic use is assessed as negligible. Sources consulted: ECHA Annex VI (no listing), SCCS/CIR (no opinion found), PubMed (no reproductive/developmental studies found), CosIng/PubChem (no hazard classification).
Pregnancy-safe products containing hexapeptide-12
Related ingredients
Frequently asked questions
- ¿Es hexapeptide-12 seguro durante el embarazo?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment for 'hexapeptide-12' was identified, and no PubMed reproductive or developmental toxicity studies for this ingredient were found in the available literature. Per CIR/SCCS default approach, absence of reproductive hazard data and absence of harmonised flags supports a default score of 0 for hazard and mechanism; expected dermal absorption for a short peptide is very low so exposure from topical cosmetic use is assessed as negligible. Sources consulted: ECHA Annex VI (no listing), SCCS/CIR (no opinion found), PubMed (no reproductive/developmental studies found), CosIng/PubChem (no hazard classification).
- ¿Es hexapeptide-12 seguro durante la lactancia?
- No data indicating reproductive or lactation toxicity, no mechanistic evidence for transfer into breastmilk, and no harmonised classifications. With no demonstrated systemic bioavailability from topical use, breastfeeding exposure is considered negligible. Sources: SCCS/CIR (no opinion), PubMed (no lactation studies), PubChem/CosIng (no hazard data).
- ¿Es hexapeptide-12 seguro para la piel del bebé?
- No infant-specific toxicity or developmental data identified. Hazard and mechanism remain 0 due to lack of evidence or harmonised classification. Dermal exposure score increased by +1 for baby skin (to 1) because peptides are not completely non‑absorbable and infant skin has a higher surface-area-to-weight ratio and immature barrier, so a low but measurable exposure is plausible even if adult absorption is negligible. Sources: general dermal absorption principles (peptide physicochemistry), CosIng/PubChem (ingredient listings), PubMed (no infant studies).
- ¿Cómo puntúa VeriMom a hexapeptide-12?
- VeriMom puntúa hexapeptide-12 en 100/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a hexapeptide-12 en el embarazo?
- Consulta nuestra lista de alternativas seguras a hexapeptide-12 según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.